Dedicated to finding novel solutions for protein misfolding diseases
Location: United States, California, San Diego
Employees: 11-50
Total raised: $181M
Founded date: 2018
Investors 3
| Date | Name | Website |
| - | Vida Ventu... | vidaventur... |
| 18.05.2023 | MPM Capita... | mpmcapital... |
| - | MPM BioImp... | mpmbioimpa... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.12.2025 | Series B | $130M | - |
| 17.11.2021 | Series A | $51M | - |
Mentions in press and media 4
| Date | Title | Description |
| 08.12.2025 | Protego Biopharma Lands $130 Million Oversubscribed Series B Financing | SAN DIEGO, CA, Protego Biopharma, a clinical-stage biotechnology company, announced the completion of an oversubscribed $130 million Series B financing. >> Click here for more funding data on Protego Biopharma >> To export Prot... |
| 17.11.2021 | Protego Biopharma Raises $51 Million Series A Financing to Advance the Treatment of Protein Misfolding Diseases | - Lightspeed Venture Partners and Vida Ventures join seed investor MPM Capital to lead Series A financing - - Protego’s proprietary technology platforms based on pioneering work from the Scripps Research labs of Dr.s Jeffery W. Kelly and R.... |
| 17.11.2021 | Protego Biopharma Raises $51 Million Series A Financing to Advance the Treatment of Protein Misfolding Diseases | - Lightspeed Venture Partners and Vida Ventures join seed investor MPM Capital to lead Series A financing - - Protego’s proprietary technology platforms based on pioneering work from the Scripps Research labs of Dr.s Jeffery W. Kelly and R.... |
| - | Protego Biopharma | “Protego” |